|
Contents |
|
|
|
|
|
|
Basic
Science
|
 
|
|
|
|
Blough MD, Westgate MR, Beauchamp D, Kelly JJ, Stechishin O, Ramirez AL, Weiss S,
Cairncross JG.
Sensitivity to temozolomide in brain tumor initiating cells
Neuro Oncol. 2010 Apr 13;. [Epub ahead of print]
.JPG)
Abstract
|
|
|
Boman BM, Wicha MS
Cancer stem cells: a step toward the cure
J
Clin Oncol. 2008 Jun 10;26(17):2795-9
Abstract |
.png)
Full Text | .png)
Reprint
|
|
|
Iwasaki
H, Suda T
Cancer
stem cells and their niche
Cancer Sci.
2009 Jul;100(7):1166-72. Epub 2009 Mar 30
Abstract |
Full Text |
Reprint
|
|
|
Massard C, Deutsch E, Soria JC
Tumour stem cell-targeted treatment: elimination or differentiation
Ann
Oncol. 2006 Nov;17(11):1620-4.
Epub 2006 May 3
Abstract |
Reprint
|
|
|
Maximilian Diehn
and Michael
F. Clarke
Cancer Stem Cells and Radiotherapy: New
Insights Into Tumor Radioresistance
JNCI Journal of the National Cancer Institute,
98(24):1755-1757; 20 December 2006; doi:10.1093/jnci/djj505
Abstract
|
Full Text |
Reprint
|
|
|
Jeremy N. Rich
Cancer Stem Cells in Radiation Resistance
Cancer Research 67, 8980-8984, October 1, 2007. doi:
10.1158/0008-5472.CAN-07-0895
Abstract |
Reprint
|
|
|
Sanchez-Garcia I, Perez-Caro Maria
Cancer Stem Cells (CSC) ablation as a treatment strategy for cancer
AACR Meeting Abstracts, Apr 2006; 2006: 73
Abstract
|
|
|
Sharma V, Dixit D, Ghosh S, Sen E.
COX-2
regulates the proliferation of glioma stem like cells.
Neurochem Int.
2011 Jul 7. [Epub ahead of print]
Abstract |
.gif) Related articles
|
|
|
Wu YY, Huang Q, Dong J, Lan Q
Correlation of stem cell niche to genesis and development of tumor stem
cells
Ai Zheng. 2008 Jan;27(1):109-12
Abstract
|
|
|
Zhou
BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB
Tumour-initiating cells: challenges and opportunities for anticancer drug
discovery
Nat
Rev Drug Discov. 2009 Oct;8(10):806-23
Abstract |
Reprint
|
|
|
Brain Tumors
|
|
|
|
|
Binello E, Germano IM.
Targeting glioma stem cells: a novel framework for brain tumors.
Cancer Sci. 2011 Aug 16.
[Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Boockvar
JA, Howard BM
Brain tumor stem cells: will understanding a new paradigm lead to improved
therapies?
Expert Rev Neurother. 2008 Apr;8(4):511-4
Abstract |
Full Text |
Reprint
|
|
|
Diamandis
P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK,
Ward RJ, Jamieson LG, Tyers M, Dirks PB.
Chemical genetics reveals a complex functional ground
state of neural stem cells
Nat Chem Biol.
2007 Apr 8; [Epub ahead of print]
PMID: 17417631 [PubMed - as supplied by publisher]
Full
Text |
Reprint
|
|
|
Guessous
F, Zhang Y, Dipierro C, Marcinkiewicz L, Sarkaria J, Schiff D, Buchanan S,
Abounader R.
An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain
Tumor Malignancy and Growth
Anticancer Agents Med Chem. 2009 Dec 16;. [Epub ahead of print]
Abstract
|
|
|
Jacques
TS, Swales A, Brzozowski MJ, Henriquez NV, Linehan JM, Mirzadeh Z, O' Malley
C, Naumann H, Alvarez-Buylla A, Brandner S
Combinations of genetic mutations in the adult neural stem cell
compartment determine brain tumour phenotypes.
EMBO J. 2009 Nov 19. [Epub
ahead of print]
Abstract
|
|
Nicoletti
F, Arcella A, Iacovelli L, Battaglia G, Giangaspero F, Melchiorri D.
Metabotropic glutamate receptors: new targets for the control of tumor
growth?
Trends
Pharmacol Sci. 2007 Apr 11;
[Epub ahead of print]
Abstract
|
|
|
Sandu
N, Schaller B
Stem cell transplantation in brain tumors: A new field for molecular imaging?
Mol Med. 2010 Jun 30;. [Epub ahead of print]
Abstract |
Reprint
|
|
|
Skog
J, Edlund K, Bergenheim AT, Wadell G
Adenoviruses 16 and CV23 efficiently transduce human low-passage brain tumor
and cancer stem cells
Mol
Ther. 2007 Dec;15(12):2140-5.
Epub 2007 Sep 18
Abstract
|
|
|
Tu
LC, Foltz G, Lin E, Hood L, Tian Q
Targeting stem cells-clinical implications for cancer therapy
Curr Stem Cell Res Ther. 2009 May;4(2):147-53
Abstract
|
|
|
Patrizia Tunici, Ph.D., Dwain Irvin,
Ph.D., M.P.H., Gentao Liu, Ph.D., Xiangpeng Yuan, Ph.D., Zeng Zhaohui,
Ph.D., Hiushan Ng, M.S., and John S. Yu, M.D.
Brain tumor stem cells: new
targets for clinical treatments?
Neurosurg Focus 20 (4):E27, April 2006
Abstract
|
Full Text |
Reprint
|
|
|
Glioblastoma
|
|
|
|
|
Ahmed
N, Salsman VS, Kew Y, Shaffer D, Powell S, Zhang YJ, Grossman RG, Heslop HE,
Gottschalk S
HER2-specific T cells target primary glioblastoma stem cells and induce
regression of autologous experimental tumors
Clin Cancer Res. 2010 Jan 15;16(2):474-85.
Abstract
|
|
|
Annabi
B, Lachambre MP, Plouffe K, Sartelet H, Béliveau R
Modulation of invasive properties of CD133(+) glioblastoma stem cells: A
role for MT1-MMP in bioactive lysophospholipid signaling
Mol Carcinog. 2009 Mar 26;. [Epub ahead of print]
Abstract
|
|
|
Beier D, Röhrl S, Pillai DR, Schwarz S, Kunz-Schughart
LA, Leukel P, Proescholdt M, Brawanski A, Bogdahn U, Trampe-Kieslich A,
Giebel B, Wischhusen J, Reifenberger G, Hau P, Beier CP
Temozolomide preferentially depletes cancer stem cells in glioblastoma
Cancer Res. 2008
Jul 15;68(14):5706-15
Abstract |
Reprint
|
|
|
Bertrand J, Begaud-Grimaud G, Bessette B,
Verdier M, Battu S, Jauberteau MO
Cancer stem cells from human glioma cell line are resistant to
Fas-induced apoptosis
Int J Oncol. 2009 Mar;34(3):717-27
Abstract
|
|
|
Castriconi
R, Daga A, Dondero A, Zona G, Poliani PL, Melotti A, Griffero F, Marubbi D,
Spaziante R, Bellora F, Moretta L, Moretta A, Corte G, Bottino C
NK cells recognize and kill human glioblastoma cells with stem cell-like
properties
J Immunol. 2009 Mar 15;182(6):3530-9
Abstract
|
|
|
Chang
CJ, Hsu CC, Yua MC, Chen KY, Tzao C, Wu WF, Chou HY, Lu KH, Chiou SH, Ma HI.
Enhanced radiosensitivity and radiation-induced apoptosis in glioma
CD133-positive cells by knockdown of SirT1 expression
Biochem Biophys Res Commun. 2009 Jan 21. [Epub ahead of print]
Abstract
|
|
|
Cheng
L, Bao S, Rich JN.
Potential therapeutic implications of cancer stem cells in glioblastoma
Biochem Pharmacol. 2010 May 10;. [Epub ahead of print]
Abstract
|
|
|
Eli E. Bar, Aneeka Chaudhry, Alex Lin, Xing Fan,
Karisa Schreck, William Matsui, Sara Piccirillo, Angelo L. Vescovi,
Francesco DiMeco, Alessandro Olivi, Charles G. Eberhart
Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like
Cancer Cells in Glioblastoma
Stem Cells Oct 2007; 25: 2524 - 2533 ; doi:10.1634/stemcells.2007-0166
Abstract
|
|
|
Chearwae W, Bright JJ
PPARgamma
agonists inhibit growth and expansion of CD133+ brain tumour stem cells
Br J Cancer.
2008 Nov 18. [Epub ahead of print]
Abstract
|
|
|
Fan
X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM,
Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG
Notch Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and
Inhibits Growth of Tumor Neurospheres and Xenografts
Histopathology. 2009 Nov;55(5):544-53
Abstract |
Full Text |
Reprint
|
|
|
Gal H, Pandi G, Kanner AA, Ram Z, Lithwick-Yanai
G, Amariglio N, Rechavi G, Givol D.
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem
cells
Biochem Biophys Res Commun. 2008 Aug 31; [Epub ahead of print]
Abstract
|
|
|
Gallia
GL, Tyler BM, Hann CL, Siu IM, Giranda VL, Vescovi AL, Brem H, Riggins GJ
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like
cells
Mol Cancer Ther. 2009 Feb;8(2):386-93. Epub 2009 Feb 10
Abstract
|
|
|
Gangemi RM, Griffero F, Marubbi D, Perera M,
Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A, Corte G
SOX2 Silencing in Glioblastoma Tumor Initiating Cells Causes Stop of
Proliferation and Loss of Tumorigenicity
Stem Cells. 2008 Oct 23; [Epub ahead of print]
Abstract
|
|
|
Glantz
M, Kesari S, Recht L, Fleischhack G, Van Horn A
Understanding the origins of gliomas and developing novel therapies:
cerebrospinal fluid and subventricular zone interplay
Semin Oncol. 2009 Aug;36(4 Suppl 2):S17-24
Abstract |
Full Text |
Reprint
|
|
|
Gürsel DB, Shin BJ, Burkhardt JK, Kesavabhotla K, Schlaff CD, Boockvar JA.
Glioblastoma
Stem-Like Cells-Biology and Therapeutic Implications.
Cancers (Basel). 2011 Jun
10;3(2):2655-2666.
Abstract |
Reprint |
Related articles
|
|
|
Hjelmeland AB, Wu Q, Wickman S, Eyler C, Heddleston J, Shi Q, Lathia JD, Macswords J,
Lee J, McLendon RE, Rich JN.
Targeting a20 decreases glioma stem cell survival and tumor growth
PLoS Biol. 2010 Feb 23;8(2):e1000319
Abstract |
Full Text |
Reprint
|
|
|
Huang Z, Cheng L, Guryanova Olga A, Wu Q and Bao
S
Cancer stem cells in glioblastoma—molecular signaling and therapeutic
targeting
Protein & Cell,
2010, Volume 1, Number 7,
July 2010, Pages 638-655
Abstract |
Reprint
|
|
|
Huszthy PC, Giroglou T, Tsinkalovsky O,
Euskirchen P, Skaftnesmo KO, Bjerkvig R, von Laer D, Miletic H
Remission of invasive, cancer stem-like glioblastoma xenografts using
lentiviral vector-mediated suicide gene therapy
PLoS One. 2009 Jul 20;4(7):e6314
Abstract |
Full Text |
Reprint
|
|
|
Jiang H, Gomez-Manzano C, Aoki H, Alonso MM,
Kondo S, McCormick F, Xu J, Kondo Y, Bekele BN, Colman H, Lang FF, Fueyo J
Examination
of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role
of autophagic cell death
J Natl
Cancer Inst. 2007 Sep 19;99(18):1410-4. Epub 2007 Sep 11
Abstract |
Full Text |
Reprint
|
|
|
Jurvansuu J, Zhao Y, Leung DS, Boulaire J, Yu YH,
Ahmed S, Wang S
Transmembrane protein 18 enhances the tropism of neural stem cells for
glioma cells
Cancer Res. 2008 Jun 15;68(12):4614-22
Abstract |
Full
Text |
Reprint
|
|
|
Kang MK, Kang SK
Pharmacologic blockade of chloride channel synergistically enhances
apoptosis of chemotherapeutic drug-resistant cancer stem cells
Biochem Biophys Res Commun. 2008 Jun 30; [Epub ahead of print]
Abstract
|
|
|
Kast
RE, Belda-Iniesta C.
Suppressing Glioblastoma Stem Cell Function by Aldehyde Dehydrogenase
Inhibition with Chloramphenicol or Disulfiram as a New Treatment Adjunct: An
Hypothesis
Curr Stem Cell Res Ther. 2009 Dec 1;. [Epub ahead of print]
Abstract
|
|
|
Kinoshita
Y, Kamitani H, Mamun MH, Wasita B, Kazuki Y, Hiratsuka M, Oshimura M,
Watanabe T
A gene delivery system with a human artificial chromosome vector based on
migration of mesenchymal stem cells towards human glioblastoma HTB14 cells
Neurol Res. 2009 Jul 8;. [Epub ahead of print]
Abstract
|
|
|
Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, Macswords J, Wu Q, Vasanji
A, McLendon RE, Hjelmeland AB, Rich JN.
Integrin alpha 6 regulates glioblastoma stem cells
Cell Stem Cell. 2010 May 7;6(5):421-32
Abstract
|
|
|
Lu
J, Zhuang Z, Song DK, Mehta GU, Ikejiri B, Mushlin H, Park DM, Lonser RR.
The effect of a PP2A inhibitor on the nuclear receptor corepressor
pathway in glioma
J Neurosurg. 2009 Dec 11;. [Epub ahead of print]
Abstract
|
|
|
Ma
HI, Chiou SH, Hueng DY, Tai LK, Huang PI, Kao CL, Chen YW, Sytwu HK.
Celecoxib and radioresistant glioblastoma-derived CD133(+) cells:
improvement in radiotherapeutic effects.
J Neurosurg. 2010 Nov 5;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Marian
CO, Cho
SK, McEllin
BM, Maher
EA, Hatanpaa
KJ, Madden
CJ, Mickey
BE, Wright
WE, Shay
JW, Bachoo
RM
The
telomerase antagonist, imetelstat, efficiently targets glioblastoma
tumor-initiating cells leading to decreased proliferation and tumor growth
Clin Cancer Res. 2010 Jan 1;16(1):154-63. Epub 2010 Jan 4
Abstract
|
|
|
McCord AM, Jamal M, Williams ES, Camphausen K,
Tofilon PJ
CD133+ glioblastoma stem-like cells are radiosensitive with a defective
DNA damage response compared with established cell lines
Clin
Cancer Res. 2009 Aug 15;15(16):5145-53. Epub 2009 Aug 11
Abstract
|
|
|
Park DM, Li J, Okamoto H, Akeju O, Kim SH,
Lubensky I, Vortmeyer A, Dambrosia J, Weil RJ, Oldfield EH, Park JK, Zhuang
Z
N-CoR pathway targeting induces glioblastoma derived cancer stem cell
differentiation
Cell Cycle. 2007 Feb 15;6(4):467-70. Epub 2007 Feb 12
Abstract |
Reprint
|
|
|
Piccirillo SG, Vescovi AL
Bone
morphogenetic proteins regulate tumorigenicity in human glioblastoma stem
cells
Ernst Schering Found Symp Proc. 2006;(5):59-81
Abstract
|
|
|
Rappa
G, Mercapide J, Anzanello F, Prasmickaite L, Xi Y, Ju J, Fodstad O, Lorico A
Growth of cancer cell lines under stem cell-like conditions has the
potential to unveil therapeutic targets
Exp Cell Res. 2008 Mar 20; [Epub ahead of print]
Abstract
|
|
|
Akihiro Otsuki, Suzanne Camilli, Ankita Patel,
Shigeru Tanaka, E. Antonio Chiocca, and Yoshinaga Saeki
Characterizing an oncolytic virotherapy targeted towards brain tumor
stem cells
AACR Meeting Abstracts, Apr 2006; 2006: 703
Abstract
|
|
|
Sara GM
Piccirillo, Angelo L Vescovi PhD
Brain
tumour stem cells: possibilities of new therapeutic strategies
Expert Opinion on Biological Therapy, August 2007, Vol. 7, No. 8, Pages
1129-1135
Abstract
|
|
|
S. G. M. Piccirillo, B. A. Reynolds, N.
Zanetti, G. Lamorte, E. Binda, G. Broggi, H. Brem, A. Olivi, F. Dimeco and
A. L. Vescovi
Bone morphogenetic
proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Nature 444, 761-765 (7 December 2006). doi:10.1038/nature05349
Abstract
|
Reprint
|
|
|
Stupp
R, Hegi ME
Targeting
brain-tumor stem cells
Nat
Biotechnol. 2007 Feb;25(2):193-4
Abstract
|
|
|
Tunici
P, Pellegatta S, Finocchiaro G.
The potential of stem cells for the treatment of brain tumors and globoid
cell leukodystrophy
Cytotechnology. 2003 Mar;41(2-3):93-101
Abstract
|
|
|
Wakimoto
H, Kesari S, Farrell CJ, Curry WT Jr, Zaupa C, Aghi M, Kuroda T, Stemmer-Rachamimov
A, Shah K, Liu TC, Jeyaretna DS, Debasitis J, Pruszak J, Martuza RL, Rabkin
SD
Human
glioblastoma-derived cancer stem cells: establishment of invasive glioma
models and treatment with oncolytic herpes simplex virus vectors
Cancer Res. 2009
Apr 15;69(8):3472-81. Epub 2009 Apr 7
Abstract
|
|
|
Wang H, Lathia JD, Wu Q, Wang J, Li Z,
Heddleston JM, Eyler CE, Elderbroom J, Gallagher J, Schuschu J, Macswords J,
Cao Y, McLendon RE, Wang XF, Hjelmeland AB, Rich JN
Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival
and Tumor Growth
Stem Cells. 2009 Aug 5;. [Epub ahead of print]
Abstract
|
|
|
Xu
Q, Liu G, Yuan X, Xu M, Wang H, Ji J, Konda B, Black KL, Yu JS.
Antigen-Specific T Cell Response from Dendritic Cell Vaccination Using
Cancer Stem-like Cell-Associated Antigens
Stem Cells. 2009 Apr 23;. [Epub ahead of print]
Abstract
|
|
|
Yuki
K, Natsume A, Yokoyama H, Kondo Y, Ohno M, Kato T, Chansakul P, Ito M, Kim
SU, Wakabayashi T.
Induction of oligodendrogenesis in glioblastoma-initiating cells by
IFN-mediated activation of STAT3 signaling
Cancer Lett. 2009 May 18;. [Epub ahead of print]
Abstract
|
|
|
Zhao
Y, Wang S
Human NT2 Neural Precursor-Derived Tumor-Infiltrating Cells as Delivery
Vehicles for Treatment of Glioblastoma
Hum Gene Ther. 2010 Jan 29;. [Epub ahead of print]
Abstract
|
|
|
Zhen
Y, Zhao S, Li Q, Li Y, Kawamoto K.
Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer
stem-like cell population in gliomas
Cancer Lett. 2009 Dec 3;. [Epub ahead of print]
Abstract
|
|
|
Zhu
X, Bidlingmaier S, Hashizume R, James CD, Berger MS, Liu B
Identification of internalizing human single-chain antibodies targeting
brain tumor sphere cells
Mol Cancer Ther. 2010 Jul;9(7):2131-41. Epub 2010 Jun 29
Abstract
|
|
|
Ziegler DS, Wright RD, Kesari S, Lemieux ME,
Tran MA, Jain M, Zawel L, Kung AL.
Resistance of human glioblastoma multiforme cells to growth factor
inhibitors is overcome by blockade of inhibitor of apoptosis proteins
J Clin Invest. 2008 Aug 1; [Epub ahead of print]
Abstract |
Full Text |
Reprint
|
|
|
Gliomas |
|
|
|
|
Bexell D, Gunnarsson S, Siesjö P, Bengzon J, Darabi A
CD133+
and nestin+ tumor-initiating cells dominate in N29 and N32 experimental
gliomas
Int
J Cancer. 2009 Feb 3. [Epub ahead of print]
Abstract
|
|
|
Bikeye
SN, Colin C, Marie Y, Vampouille R, Ravassard P, Rousseau A, Boisselier B,
Idbaih A, Calvo CF, Leuraud P, Lassalle M, El Hallani S, Delattre JY, Sanson
M.
ASPM-associated stem cell proliferation is involved in malignant progression
of gliomas and constitutes an attractive therapeutic target
Cancer Cell Int. 2010 Jan 11;10:1
Abstract |
Full Text |
Reprint
|
|
|
Blough
MD, Beauchamp DC, Westgate MR, Kelly JJ, Cairncross JG
Effect
of aberrant p53 function on temozolomide sensitivity of glioma cell lines
and brain tumor initiating cells from glioblastoma
J
Neurooncol. 2010 Jul 1. [Epub ahead of print]
Abstract
|
|
|
Burkhardt JK, Shin BJ, Boockvar JA.
Neural
stem cells and glioma stem-like cells respond differently to
chemotherapeutic drugs: selectivity at the cellular level.
Neurosurgery. 2011 Jun;68(6):N21-2.
No abstract available.
Abstract |
Related articles
|
|
|
Charles
N, Ozawa T, Squatrito M, Bleau AM, Brennan CW, Hambardzumyan D, Holland EC
Perivascular Nitric Oxide Activates Notch Signaling and Promotes Stem-like
Character in PDGF-Induced Glioma Cells
Cell Stem Cell. 2010 Feb 5;6(2):141-152
Abstract
|
|
|
Eyler CE, Foo WC, Lafiura KM, McLendon RE,
Hjelmeland AB, Rich JN.
Brain Cancer Stem Cells Display Preferential Sensitivity to Akt
Inhibition
Stem Cells. 2008 Sep 18; [Epub ahead of print]
Abstract
|
|
|
Friedman GK, Langford CP, Coleman JM, Cassady KA, Parker JN, Markert JM, Yancey
Gillespie G.
Engineered herpes simplex viruses efficiently infect and kill CD133+ human
glioma xenograft cells that express CD111
J Neurooncol. 2009 Jun 12;. [Epub ahead of print]
Abstract
|
|
|
Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G,
Raychaudhury A, Newton HB, Chiocca EA, Lawler S
Targeting
of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits
glioma proliferation and self-renewal
Cancer Res. 2008
Nov 15;68(22):9125-30
Abstract
|
|
|
Gong X, Schwartz PH, Linskey ME, Bota DA.
Neural stem/progenitors and glioma stem-like cells have differential sensitivity to
chemotherapy.
Neurology. 2011 Mar
29;76(13):1126-34. Epub 2011 Feb 23.
Abstract |
Reprint |
Related articles
|
|
|
Gu
C, Li S, Tokuyama T, Yokota N, Namba H.
Therapeutic effect of genetically engineered mesenchymal stem cells in
rat experimental leptomeningeal glioma model
Cancer Lett. 2009 Nov 26;. [Epub ahead of print]
Abstract
|
|
|
Guessous
F, Zhang Y, Kofman A, Catania A, Li Y, Schiff D, Purow B, Abounader R.
microRNA-34a is tumor suppressive in brain tumors and glioma stem cells
Cell Cycle. 2010 Mar 18;9(6). [Epub ahead of print]
Abstract |
Reprint
|
|
|
Hyun
KH, Yoon CH, Kim RK, Lim EJ, An S, Park MJ, Hyun JW, Suh Y, Kim MJ, Lee SJ.
Eckol suppresses maintenance of
stemness and malignancies in glioma stem-like cells.
Toxicol Appl Pharmacol. 2011
Apr 14;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Laks
DR, Visnyei K, Kornblum HI
Brain
tumor stem cells as therapeutic targets in models of glioma
Yonsei
Med J. 2010 Sep;51(5):633-40. Published online 2010 July 15
Abstract |
Full Text |
Reprint
|
|
|
Li
Z, Wang H, Eyler CE, Rich JN
Turning cancer stem cells inside-out: an exploration of glioma stem cell
signaling pathways
J Biol Chem. 2009 Mar 13;. [Epub ahead of print]
Abstract |
Reprint
|
|
|
Neman
J, Jandial R
Decreasing glioma recurrence through adjuvant cancer stem cell inhibition
Biologics. 2010 Jun 24;4:157-62
Abstract |
Full Text |
Reprint
|
|
|
Sasportas
LS, Kasmieh R, Wakimoto H, Hingtgen S, van de Water JA, Mohapatra G,
Figueiredo JL, Martuza RL, Weissleder R, Shah K
Assessment of therapeutic efficacy and fate of engineered human mesenchymal
stem cells for cancer therapy
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4822-7. Epub 2009 Mar 5
Abstract
|
|
|
Shi
L, Zhang J, Pan T, Zhou J, Gong W, Liu N, Fu Z, You Y.
MiR-125b is critical for the suppression of human U251 glioma stem cell
proliferation
Brain Res. 2009 Nov 27;. [Epub ahead of print]
Abstract
|
|
|
Thon N, Damianoff K, Hegermann J, Grau S, Krebs
B, Schnell O, Tonn JC, Goldbrunner R.
Presence of pluripotent CD133(+) cells correlates with malignancy of
gliomas
Mol Cell Neurosci. 2008 Aug 7; [Epub ahead of print]
Abstract
|
|
|
Toda
M
Identification of antigen against brain tumor stem cell and application for
treatment of glioma
Gan To Kagaku Ryoho. 2010 Jun;37(6):1016-8
Abstract
|
|
|
Wang
J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN,
Sullenger BA
Notch
promotes radioresistance of glioma stem cells
Stem
Cells. 2010 Jan;28(1):17-28. Epub 2009 Nov 17
Abstract |
Full Text |
Reprint
|
|
|
Gliomas
(High-Grade) |
|
|
|
|
Aguado
T, Carracedo A, Julien B, Velasco G, Milman G, Mechoulam R, Alvarez L, Guzmán
M, Galve-Roperh I
Cannabinoids induce glioma stem-like cell differentiation and inhibit
gliomagenesis
J Biol
Chem. 2007 Mar 2;282(9):6854-62.
Epub 2007 Jan 2
Abstract |
Full Text |
Reprint
|
|
|
Alonso
MM, Jiang H, Gomez-Manzano C, Fueyo J.
Targeting brain tumor stem
cells with oncolytic adenoviruses.
Methods Mol Biol.
2012;797:111-25.
Abstract |
Related articles
|
|
|
Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H,
McLendon RE, Hjelmeland AB, Rich JN.
Targeting cancer stem cells through L1CAM suppresses glioma growth
Cancer Res. 2008
Aug 1;68(15):6043-8
Abstract |
Reprint
|
|
|
Brown
CE, Starr R, Martinez C, Aguilar B, D'Apuzzo M, Todorov I, Shih CC, Badie B,
Hudecek M, Riddell SR, Jensen MC.
Recognition and Killing of Brain Tumor Stem-Like Initiating Cells by CD8+
Cytolytic T Cells
Cancer Res. 2009 Nov 10;. [Epub ahead of print]
Abstract
|
|
|
Campos
B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, Ahmadi R, Lohr J,
Dictus C, Gdynia G, Combs SE, Goidts V, Helmke BM, Eckstein V, Roth W,
Beckhove P, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende C
Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma
Cells
Clin Cancer Res. 2010 May 4;. [Epub ahead of print]
Abstract
|
|
|
Chamberlain MC, Bota DA, Linskey ME, Schwartz PH.
Neural stem/progenitors and glioma stem-like cells have differential
sensitivity to chemotherapy.
Neurology. 2011 Nov
29;77(22):e135-6.
Abstract |
Full text |
Related articles
|
|
|
Evers
P, Lee PP, Demarco J, Agazaryan N, Sayre JW, Selch M, Pajonk F.
Irradiation of the Potential Cancer Stem Cell Niches in the Adult Brain
Improves Progression-free Survival of Patients with Malignant Glioma
BMC Cancer. 2010 Jul 21;10(1):384. [Epub ahead of print]
Abstract |
Reprint
|
|
|
Folkins
C, Man S, Xu P, Shaked Y, Hicklin DJ, Kerbel RS
Anticancer therapies combining antiangiogenic and tumor cell cytotoxic
effects reduce the tumor stem-like cell fraction in glioma xenograft tumors
Cancer Res. 2007
Apr 15;67(8):3560-4
Abstract |
Reprint
|
|
|
A. G. Gilg, S. L. Tye, L. B. Tolliver, W. G.
Wheeler, R. P. Visconti, J. D. Duncan, F. V. Kostova, L. N. Bolds, B. P.
Toole, and B. L. Maria
Targeting Hyaluronan Interactions in Malignant Gliomas and Their
Drug-Resistant Multipotent Progenitors
Clin. Cancer Res., March 15, 2008; 14(6): 1804 - 1813
Abstract
|
|
|
Gong X, Schwartz PH, Linskey ME, Bota DA.
Neural stem/progenitors and glioma stem-like cells have differential sensitivity to
chemotherapy.
Neurology. 2011 Mar
29;76(13):1126-34. Epub 2011 Feb 23.
Abstract |
Reprint |
Related articles
|
|
|
Hua W, Yao Y, Chu Y, Zhong P, Sheng X, Xiao B, Wu J, Yang B, Mao Y, Zhou L.
The
CD133+ tumor stem-like cell-associated antigen may elicit highly
intense immune responses against human malignant glioma.
J Neurooncol.
2011 Apr 11. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Jiang
H, Fueyo J.
Eradication of brain tumor stem cells with an oncolytic adenovirus
Discov Med. 2010 Jul;10(50):24-8. Published on July 5, 2010
Abstract |
Full Text
|
|
|
Kendall SE, Najbauer J, Johnston HF, Metz MZ, Li
S, Bowers M, Garcia E, Kim SU, Barish ME, Aboody KS, Glackin CA
Neural Stem Cell Targeting of Glioma is Dependent on PI3K Signaling
Stem Cells. 2008 Mar 13; [Epub ahead of print]
Abstract |
Reprint |
Supplemental
Data
|
|
|
Laks
DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, Foran I, Yong WH,
Vinters HV, Liau LM, Lazareff JA, Mischel PS, Cloughesy TF, Horvath S,
Kornblum HI
Neurosphere formation is an independent predictor of clinical outcome in
malignant glioma
Stem Cells. 2009 Apr;27(4):980-7
Abstract
|
|
|
Lee DH, Ahn Y, Kim SU, Wang KC, Cho BK, Phi JH,
Park IH, Black PM, Carroll RS, Lee J, Kim SK
Targeting rat brainstem glioma using human neural stem cells and human
mesenchymal stem cells
Clin
Cancer Res. 2009 Aug 1;15(15):4925-34. Epub 2009 Jul 28
Abstract
|
|
|
Oh MC, Lim DA
Novel treatment strategies for malignant gliomas using neural stem cells
Neurotherapeutics. 2009 Jul;6(3):458-64
Abstract |
Full Text |
Reprint
|
|
|
Pellegatta
S, Finocchiaro G
Dendritic cell vaccines for cancer stem cells
Methods Mol Biol. 2009;568:233-47.
Abstract
|
|
|
Serena Pellegatta, Pietro Luigi Poliani, Daniela
Corno, Francesca Menghi, Francesco Ghielmetti, Blanca Suarez-Merino,
Valentina Caldera, Sara Nava, Maria Ravanini, Fabio Facchetti, Maria Grazia
Bruzzone, and Gaetano Finocchiaro
Neurospheres Enriched in Cancer Stem–Like Cells Are Highly
Effective in Eliciting a Dendritic Cell–Mediated Immune Response against
Malignant Gliomas
Cancer Res 2006 Nov 1; 66: 10247-10252
Abstract
|
Reprint
|
|
|
Sauvageot CM, Weatherbee JL, Kesari S, Winters
SE, Barnes J, Dellagatta J, Ramakrishna NR, Stiles CD, Kung AL, Kieran MW,
Wen PY.
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and
tumorigenic glioma stem cells
Neuro Oncol. 2008 Aug 5; [Epub ahead of print]
Abstract
|
|
|
Wu
A, Wiesner S, Xiao J, Ericson K, Chen W, Hall WA, Low WC, Ohlfest JR
Expression of MHC I and NK ligands on human CD133+ glioma cells: possible
targets of immunotherapy
J Neurooncol.
2007 Jun;83(2):121-31.
Epub 2006 Nov 1. Erratum in: J Neurooncol. 2007 Jun;83(2):133
Abstract |
Reprint
|
|
|
Medulloblastoma
|
|
|
|
|
Annabi B, Rojas-Sutterlin S, Laflamme C,
Lachambre MP, Rolland Y, Sartelet H, Béliveau R
Tumor environment dictates medulloblastoma cancer stem cell expression
and invasive phenotype
Mol Cancer
Res. 2008 Jun;6(6):907-16
Abstract |
Full Text |
Reprint
|
|
|
Elamin
MH, Shinwari Z, Hendrayani SF, Al-Hindi H, Al-Shail E, Khafaga Y, Al-Kofide
A, Aboussekhra A
Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers
apoptosis in medulloblastoma cells
Mol Carcinog. 2009 Dec 18;. [Epub ahead of print]
Abstract
|
|
|
Fan X, Eberhart CG
Medulloblastoma stem cells
J
Clin Oncol. 2008 Jun 10;26(17):2821-7
Abstract
|
|
|
Fan
X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, Eberhart CG
Notch
pathway inhibition depletes stem-like cells and blocks engraftment in
embryonal brain tumors
Cancer Res.
2006 Aug 1;66(15):7445-52
Abstract |
Full Text |
Reprint
|
|
|
Lu KH, Chen YW, Tsai PH, Tsai ML, Lee YY, Chiang CY, Kao CL, Chiou SH, Ku
HH,
Lin CH, Chen YJ
Evaluation
of radiotherapy effect in resveratrol-treated medulloblastoma cancer
stem-like cells
Childs
Nerv Syst. 2009 Feb 19. [Epub ahead of print]
Abstract
|
|
|
Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan
CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, LoRusso PM, Von Hoff DD,
de Sauvage FJ, Low JA
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449
N Engl J Med.
2009 Sep 17;361(12):1173-8. Epub 2009 Sep 2
Abstract |
Full Text |
Reprint
|
|
|
Xing Fan, William Matsui, Leila Khaki, Jiong
Chun, Yue-Ming Li, and Charles G. Eberhart
Notch pathway blockade targets medulloblastoma-initiating cancer
stem cells
AACR Meeting Abstracts, Apr 2006; 2006: 1053
Abstract
|
|
|
Metastasis
|
|
|
|
|
M. Mimeault, R. Hauke, P. P. Mehta, S. K. Batra
Recent advances in
cancer stem/progenitor cell research: therapeutic implications for
overcoming resistance to the most aggressive cancers
J
Cell Mol Med. Volume 11, CNO 5, Page 981-1011, Sep 2007, doi:
10.1111/j.1582-4934.2007.00088.x
Abstract |
Full Text |
Reprint
|
|
|
Neuroblastoma
|
|
|
|
|
Tsuchida R, Das B, Yeger H, Koren G, Shibuya M,
Thorner PS, Baruchel S, Malkin D.
Cisplatin treatment increases survival and expansion of a highly
tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine
signaling
Oncogene. 2008 Jun 26;27(28):3923-34.
Epub 2008 Mar 10
Abstract
|
|
|
Pediatric
Patients
|
|
|
|
|
Calvin
Li S, Han YP, Dethlefs BA, Günter Loudon W
Therapeutic Window of Stem Cell Potential for Targeting Pediatric Malignant
Brain Tumors: An Opportunity for Stem Cell Therapy
Stem Cell Rev Rep. 2009 Apr 23;. [Epub ahead of print]
Abstract |
Full Text |
Reprint
|
|
|
Thirant
C, Bessette B, Varlet P, Puget S, Cadusseau J, Dos Reis Tavares S, Studler
JM, Silvestre DC, Susini A, Villa C, Miquel C, Bogeas A, Surena AL,
Dias-Morais A, Léonard N, Pflumio F, Biéche I, Boussin FD, Sainte-Rose
C, Grill J, Daumas-Duport C, Chneiweiss H, Junier MP.
Clinical relevance of tumor cells with stem-like properties in pediatric
brain tumors.
PLoS One. 2011 Jan 28;6(1):e16375.
Abstract |
Reprint |
Related articles
|
|
|
Targeted CSC Therapies
|
|
|
|
|
Evers P, Lee PP, DeMarco J, Agazaryan N, Sayre JW, Selch M, Pajonk F.
Irradiation of the potential cancer stem cell niches in the adult brain
improves progression-free survival of patients with malignant glioma.
BMC Cancer. 2010 Jul 21;10:384
Abstract |
Reprint |
Related articles
|
|
|
Vlashi E, Pajonk F.
Targeted cancer stem cell therapies start with proper identification of the
target.
Mol Cancer Res.
2010 Feb;8(2):291; author reply 291. Epub 2010 Feb 9.
Abstract |
Reprint |
Related articles
|
|
|
Vlashi E, McBride WH, Pajonk F.
Radiation responses of cancer stem cells.
J Cell Biochem.
2009 Oct 1;108(2):339-42.
Abstract |
Reprint |
Related articles
|
|
|
Vlashi E, Kim K, Lagadec C, Donna LD, McDonald JT, Eghbali M, Sayre JW,
Stefani E, McBride W, Pajonk F.
In vivo imaging, tracking, and targeting of cancer stem cells.
J Natl
Cancer Inst. 2009 Mar 4;101(5):350-9. Epub 2009 Feb 24. Erratum in: J
Natl Cancer Inst. 2009 Jun 3;101(11):833.
Abstract |
Reprint |
Erratum
| Related articles
|
|
|
Woodward WA, Bristow RG, Clarke MF, Coppes RP, Cristofanilli M, Duda DG,
Fike JR, Hambardzumyan D, Hill RP, Jordan CT, Milas L, Pajonk F, Curran WJ,
Dicker AP, Chen Y.
Radiation Therapy Oncology Group translational research program stem cell
symposium: incorporating stem cell hypotheses into clinical trials.
Int
J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1580-91. Epub 2009 Jun 17.
Abstract |
Related articles
|
|
|
Telomere
Maintenance
|
|
|
|
|
Castelo-Branco P, Zhang C, Lipman T, Fujitani M, Hansford L, Clarke I,
Harley CB, Tressler R, Malkin D, Walker E, Kaplan DR, Dirks P, Tabori U.
Neural
Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely
Targeted for Telomerase Inhibition.
Clin
Cancer Res. 2011 Jan 1;17(1):111-21.
Abstract |
Reprint |
.gif)
News
News
|
Related articles
|
|
|
Hjelmeland AB, Rich JN.
Molecular
Targeting of Neural Cancer Stem Cells: TTAGGG, You're It!
Clin
Cancer Res. 2011 Jan 1;17(1):3-5.
Abstract |
Related articles
|
|
|
|
